Evidence map›Paper›PMID 37242442›Full record

ArticlePharmaceuticals (Basel, Switzerland)2023

Screening of Antiglaucoma, Antidiabetic, Anti-Alzheimer, and Antioxidant Activities of

Leyla Güven, Adem Erturk, Fatma Demirkaya Miloğlu, Saleh Alwasel, İlhami Gulcin

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
24.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 61 citations in OpenAlex.

  1. Mechanistic convergence ofIBRO neuroscience reports · 2026
    Article
  2. Plants (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Antioxidants: a comprehensive review.Archives of toxicology · 2025
    Review
  10. Article
  11. Article
  12. Review
  13. Therapeutic potential ofFrontiers in chemistry · 2025
    Article
  14. Article
  15. Exploring Water-Soluble South AfricanCurrent issues in molecular biology · 2024
    Article
  16. Article
  17. Anti-Cholinergic Effects of the Phenolic Extract from thePharmaceuticals (Basel, Switzerland) · 2024
    Article
  18. Review
  19. Phenolic Content Analysis of Two Species Belonging to theMolecules (Basel, Switzerland) · 2024
    Article
  20. Profiling ofFrontiers in nutrition · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Leyla GüvenDepartment of Pharmaceutical Botany, Faculty of Pharmacy, Ataturk University, 25240 Erzurum, Turkey.ORCID 0000-0002-3189-6415
Adem ErturkDepartment of Pharmacy Services, Hınıs Vocational School, Ataturk University, 25600 Erzurum, Turkey.
Fatma Demirkaya MiloğluDepartment of Analytical Chemistry, Faculty of Pharmacy, Ataturk University, 25240 Erzurum, Turkey.
Saleh AlwaselDepartment of Zoology, College of Science, King Saud University, Riyadh 11362, Saudi Arabia.
İlhami GulcinDepartment of Chemistry, Faculty of Science, Ataturk University, 25240 Erzurum, Turkey.ORCID 0000-0001-5993-1668
Atatürk University · TRKing Saud University · SA

Funding

King Saud University RSP-2023/59Turkish Academy of Sciences TÜBA
6 · The paper itself

Abstract

Astragalus species are traditionally used for diabetes, ulcers, leukemia, wounds, stomachaches, sore throats, abdominal pain, and toothaches. Although the preventive effects of Astragalus species against diseases are known, there is no record of the therapeutic effects of

Indexed as

acetylcholinesteraseantioxidant activityastragaluscarbonic anhydraseLC-MS/MSα-amylaseα-glycosidase

Identifiers

PMID37242442
PMCPMC10221919
OpenAlexW4367316217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.